Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

Quotes

Analysis

Analyst Ratings

News

Press Releases

Twitter

Media Mentions

Ownership

Earnings

BG Medicine, Inc. (BGMD) 2.00 -0.07
Price Open:1.75Day's Range:0.00000 - 4.48000
Price Close:1.7952wk Range:0.00000 - 12.80
Price Day Change:-0.07Volume:92,707
Price % Change:-3.91Market Cap:47.4M
Bid:1.72000PE Ratio:0
Ask:2.00000EPS Diluted:-0.998
Trade BGMD NOW!

The Latest On BGMD

Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patients 4/10/13 8:06am
Earnings Scheduled For March 13, 2013 3/13/13 4:21am
BG Medicine Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients 2/27/13 9:40am
BG Medicine Announces Offering of Common Stock 1/24/13 5:36pm
Benzinga's Small Cap Movers for Thursday January 3, 2013 1/3/13 8:42pm
Morning Market Movers 1/3/13 11:02am
BG Medicine Announces Obtaining CE Mark, Launch of Automated BGM Galectin-3 Test 1/2/13 5:15pm
Morning Market Movers 12/12/12 10:53am
Benzinga's Top Pre-Market Gainers 12/12/12 9:12am
Benzinga's Small Cap Movers for Tuesday December 11, 2012 12/11/12 8:09pm
Top Narrow Based Indexes For December 11, 2012 12/11/12 11:42am
Morning Market Movers 12/11/12 10:52am
more
Press Releases
Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 5/22/13 Newswire
BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 5/10/13 GlobeNewswire
BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer 5/9/13 GlobeNewswire
BG Medicine Reports 2013 First Quarter Financial Results 5/9/13 GlobeNewswire
Trenton Health Team Adopts Novel Diagnostic Tool, BGM Galectin-3(R) Test, to Reduce Hospital Readmissions 5/8/13 GlobeNewswire
BG Medicine to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 9, 2013 5/2/13 GlobeNewswire
Syros Pharmaceuticals Launches with $30 Million Series A Financing 4/11/13 Business Wire
BG Medicine Welcomes CE Mark for Galectin-3 Test 4/10/13 GlobeNewswire
Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patients 4/10/13 Newswire
BG Medicine Reports Fourth Quarter and Full Year 2012 Financial Results and Provides 2013 Outlook 3/13/13 GlobeNewswire
BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday, March 13, 2013 3/6/13 GlobeNewswire
BG Medicine Highlights Role of Galectin-3 Testing in Combating Hospital Readmissions at the American College of Cardiology's (ACC) 62nd Annual Scientific Session & Expo 3/6/13 GlobeNewswire

Get the latest BGMD stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for BG Medicine, Inc. stock price.

Partner Headlines
Zacks #1 Rank Additions for Thursday - Tale of the Tape 5/2/13
Zacks Rank #1 Addition for Friday - Tale of the Tape 4/19/13
Abbott Launches Automated Solution - Analyst Blog 4/18/13
Abbott's Heart FailureTest in Europe - Analyst Blog 4/11/13
BG Medicine, Inc. (BGMD) Executive Chairman Stephane Bancel buys 100,000 Shares 11/19/12
New Ratings: BGMD, FLDM, FMS, GRMN, MACK, TRMB 8/31/12
Health Care Sector Wrap 8/20/12
Health Care Sector Wrap 7/25/12
Health Care Sector Wrap 5/31/12
Health Care Sector Wrap 5/30/12
BG Medicine Inc. (BGMD) CEO Eric Bouvier buys 10,000 Shares 5/24/12
BG Medicine Inc. (BGMD) Executive Chairman Stephane Bancel buys 5,008 Shares 5/23/12